Metabolomics: an emerging post-genomic tool for nutrition

The post-genomic era has been driven by the development of technologies that allow the function of cells and whole organisms to be explored at the molecular level. Metabolomics is concerned with the measurement of global sets of low-molecular-weight metabolites. Metabolite profiles of body fluids or...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of nutrition Vol. 92; no. 4; pp. 549 - 555
Main Authors Whitfield, Phillip D., German, Alexander J., Noble, Peter-John M.
Format Journal Article
LanguageEnglish
Published Cambridge, UK Cambridge University Press 01.10.2004
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The post-genomic era has been driven by the development of technologies that allow the function of cells and whole organisms to be explored at the molecular level. Metabolomics is concerned with the measurement of global sets of low-molecular-weight metabolites. Metabolite profiles of body fluids or tissues can be regarded as important indicators of physiological or pathological states. Such profiles may provide a more comprehensive view of cellular control mechanisms in man and animals, and raise the possibility of identifying surrogate markers of disease. Metabolomic approaches use analytical techniques such as NMR spectroscopy and MS to measure populations of low-molecular-weight metabolites in biological samples. Advanced statistical and bioinformatic tools are then employed to maximise the recovery of information and interpret the large datasets that are generated. Metabolomics has already been used to study toxicological mechanisms and disease processes and offers enormous potential as a means of investigating the complex relationship between nutrition and metabolism. Examples include the metabolism of dietary substrates, drug-induced disturbances of lipid metabolites in type 2 diabetes mellitus and the therapeutic effects of vitamin supplementation in the treatment of chronic metabolic disorders.
Bibliography:ark:/67375/6GQ-VB3QMVBZ-X
PII:S0007114504002053
ArticleID:00205
istex:BFB7730BD1E17C55C2CB1EBDECBBBA34B6C8AFAC
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0007-1145
1475-2662
DOI:10.1079/BJN20041243